No Data
No Data
RBC Capital Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $136
RBC Capital Reaffirms Their Buy Rating on Addus Homecare (ADUS)
Addus HomeCare's (NASDAQ:ADUS) One-year Total Shareholder Returns Outpace the Underlying Earnings Growth
Addus HomeCare to Participate in Stephens Annual Investment Conference
Addus HomeCare's (NASDAQ:ADUS) Promising Earnings May Rest On Soft Foundations
TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $141